RCT
Published: Sep 2008
ACE Report #5106
Ace Report Cover Tumour

Ewing sarcoma treatment: assessment of cyclophosphamide and etoposide on survival rates

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients-

J Clin Oncol. 2008 Sep 20;26(27):4385-93. doi: 10.1200/JCO.2008.16.5720

Contributing Authors: M Paulussen AW Craft I Lewis A Hackshaw C Douglas J Dunst A Schuck W Winkelmann G Köhler C Poremba A Zoubek R Ladenstein H van den Berg A Hunold A Cassoni D Spooner R Grimer J Whelan A McTiernan H Jürgens European Intergroup Cooperativ

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Explore some of our unlocked reports below!

Treatment of osteoarthritis: A role for education programmes?
The prevalence of intimate partner violence in women presenting to orthopaedic clinics
Osteoporosis Choice decision aid improves treatment experience of clinicians and patients
Protein-Rich nutritional supplementation shows limited efficacy in elderly hip fractures
CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.